Babette Heyer

Title: Babette Heyer: Innovator in Avian Stem Cell Research

Introduction

Babette Heyer is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of biotechnology, particularly in the area of avian embryonic stem cell research. Her innovative work has the potential to advance genetic studies and transgenic applications in birds.

Latest Patents

Babette Heyer holds a patent for her invention titled "Chimeric bird from embryonic stem cells." This patent describes a method for sustaining cultures of avian embryonic stem cells. The process involves injecting these stem cells into recipient embryos, resulting in chimeras that exhibit a significant contribution from the embryonic stem cell phenotype. The transgenes encoding exogenous proteins are stably integrated into the embryonic stem cells and are present in the somatic tissue of the resulting chimeras. These transgenes can encode proteins expressed in various tissue types, including endodermal, ectodermal, mesodermal, or extra embryonic tissue. Breeding the resulting chimera yields transgenic birds with genomes that include exogenous DNA.

Career Highlights

Babette Heyer is currently associated with Origen Therapeutics, Inc., where she continues her research and development in the field of biotechnology. Her work has garnered attention for its innovative approach to genetic engineering in avian species.

Collaborations

Some of her notable coworkers include Marie-Cecile Van De Lavoir and Robert Etches, who contribute to the collaborative efforts in advancing research in this specialized field.

Conclusion

Babette Heyer is a trailblazer in avian stem cell research, with her patent paving the way for future advancements in genetic engineering. Her contributions are poised to have a lasting impact on the field of biotechnology.